Guide to buying Evotec SE stock in Canada

Evotec SE is a drug manufacturers - specialty & generic business based in the US. Evotec SE stocks (EVO) are listed on the NASDAQ, and all prices are listed in US Dollars.

At its last market close, Evotec SE stock price was $2.72, which is a decrease of 2.86% over the previous week. Evotec SE employs 4,526 staff and has a trailing 12-month revenue of around $745 million.

Keep reading to see up-to-date Evotec SE stock price and performance data, along with a step-by-step guide for how to buy Evotec SE stock in Canada.

Evotec SE (EVO) stock summary

Company stock name	Evotec SE ADR
Stock ticker symbol	EVO
Exchange	NASDAQ
Open	$2.71
High	$2.74
Low	$2.70
Close	$2.72
Adjusted closing	$2.72
Volume The number of stocks traded during the day	14,155
52-week stock price range	$2.31 – $4.44
Where to buy Evotec SE stock	Buy on Questrade

The values in this table are accurate as of the market close on June 11, 2026, and all amounts are in USD.

Can I buy Evotec SE stock in Canada?

Yes, you can buy Evotec SE stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NASDAQ exchange. Platforms like Interactive Brokers will allow you to directly buy Evotec SE stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Evotec SE ADR stock

Evotec SE stock chart (NASDAQ: EVO)

This chart tracks Evotec SE stock price performance over time.

Evotec SE stock price

Evotec SE's stock price at the last available market close was $2.72 (as of June 11, 2026). For comparison, seven days ago Evotec SE's stock price was $2.80. A full 30 days ago it was $2.72, and a year ago it was $4.27.

Is Evotec SE stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Evotec SE stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Evotec SE stock on the TSX?

No, you cannot buy Evotec SE stock on the TSX because Evotec SE stock is not listed on the TSX. Instead, Evotec SE stock is listed on the NASDAQ under the symbol "EVO."

That said, if you're wondering how to invest in Evotec SE stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NASDAQ, like Questrade or Wealthsimple.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Evotec SE stock dividends

Evotec SE is not expected to pay a dividend over the next 12 months.

Evotec SE stock performance metrics

Here are some common key metrics for Evotec SE stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Evotec SE's PEG ratio

  Evotec SE's price/earnings-to-growth (PEG) ratio comes out to about 1.4223.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Evotec SE's expected earnings growth.

Has Evotec SE stock ever split?

Evotec SE's stocks were split on a 4:1 basis on October 19, 2021. So, if you had owned 1 share the day before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Evotec SE stocks, just the quantity.

However, indirectly, the new 300% higher stock price could have impacted the market appetite for Evotec SE stocks, which in turn could have impacted Evotec SE's stock price.

How volatile is Evotec SE stock?

Over the last 12 months, Evotec SE's stocks price has ranged from $2.31 to as high as $4.44. Evotec SE's beta measurement of stock volatility is 1.30. For comparison, the market () average beta is 1. This would suggest that Evotec SE's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Evotec SE's beta stock volatility rating.

Evotec SE ADR company and revenue performance

Market Capitalization The total market value of Evotec SE's outstanding shares	$994.5 million
Gross profit (TTM)	$79.4 million
Profit margin	-26.02%
Revenue (TTM)	$745 million
Return on assets (TTM)	-3.14%
Return on equity (TTM)	-24.06%
Earnings per share (TTM)	-$0.63
50-day moving stock price average The average share price over the last 50 days	$2.90
200-day moving stock price average The average share price over the last 200 days	$3.28

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on June 11, 2026.

Evotec SE company profile

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just " Evotec Biologics.

The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health.

The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB.

Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital.

• Common company-related questions about Evotec SE

  What percentage of Evotec SE is owned by institutions?
  Currently 2.154% of Evotec SE stocks are held by institutions.

  How many people work for Evotec SE?
  Latest data suggests 4,526 work at Evotec SE.

  When does the fiscal year end for Evotec SE?
  Evotec SE's fiscal year ends in December.

  Where is Evotec SE based?
  Evotec SE's address is: Essener Bogen 7, Hamburg, Germany, 22419

  What is Evotec SE's ISIN number?
  Evotec SE's international securities identification number is: US30050E1055

Compare trading platforms to buy Evotec SE stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Evotec SE stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Evotec SE stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Evotec SE stock

• Can I buy Evotec SE stock directly as a Canadian investor?

  Yes, Canadian investors can buy Evotec SE stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Evotec SE stock in our table here.

• How much is Evotec SE stock worth?

  As of the last market close (on June 11, 2026), Evotec SE stock is worth $2.72 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Evotec SE stock?

  Yes, it may be possible to buy fractional shares of Evotec SE stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Evotec SE stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  4 of 4 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted 9.6 Excellent Questrade Exclusive	9.6 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA, Margin	$0	$0	Finder exclusive: Get $125 cash back with the Questrade promo code FINDER125. Offer ends June 22, 2026. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  Promoted 8.6 Great Wealthsimple Investing	8.6 Great	Stocks, Options, ETFs, Cryptocurrency	RRSP, TFSA, Personal, Margin	$0	$0	Get a 1% match cash bonus on eligible $25,000+ transfers from other financial institutions to your Wealthsimple Self-directed Investing and Managed Investing accounts. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  9.4 Excellent Interactive Brokers	9.4 Excellent	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint, Business, FHSA, Margin	Min $1.00, Max 0.5%	$0	View details Compare product selection Compare	loading
  8.6 Great Moomoo	8.6 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA, Margin	$1.49/stock	$0	Get up to 30 free stocks, 6% on uninvested cash, $0 commission-free trades for 30 days and up to $2,300 in cash rewards. Offer ends August 31, 2026. T&Cs apply.	View details Compare product selection Compare	loading

  loading

  Load More

  Showing 4 of 4 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.